HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes.

Abstract
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is an uncommon cutaneous lymphoma that has been proposed as a distinct clinicopathologic entity, but studies of SPTCL are limited. We studied the clinicopathologic, immunophenotypic, and genetic features of 11 SPTCLs. All cases had a variable admixture of pleomorphic small, medium, or large lymphocytes and histiocytes infiltrating the subcutis in a lobular panniculitis-like pattern. A granulomatous reaction was seen in three cases and erythrophagocytosis in four. Karyorrhexis and fat necrosis were present in all cases. Angioinvasion was seen in seven SPTCLs; four had areas of coagulation necrosis. All cases expressed T-cell-associated antigens (CD3epsilon, CD45RO, or CD43) and T-cell receptors (TCR); nine expressed alphabeta TCRs and two expressed gammadelta TCRs. T-cell receptor-gamma, TCRbeta, or TCRdelta genes were clonally rearranged in 8 of 10 cases studied. Both gammadelta SPTCLs expressed Vdelta2+ TCRs and were CD4-, CD8- and CD56+. CD56 was negative in seven of nine alphabeta SPTCLs and inconclusive in the other two. Six of nine alphabeta SPTCLs were CD8+; the CD4/CD8 phenotypes were indeterminate in the other three. Cytolytic granule-associated proteins were expressed by all SPTCLs (11 of 11 were TIA-1+, 4 of 4 were perforin+). In situ hybridization for Epstein-Barr virus-encoded RNA (EBER-1) was negative in all cases. Most patients responded to systemic chemotherapy or local radiation therapy. Seven patients are alive: four without disease (19-73 months) and three with disease (32-72 months); four died: three of disease (3-25 months) and one without disease (42 months). We conclude that SPTCLs are clonal, EBV-, cytotoxic T-cell lymphomas derived from alphabeta T-cells or gammadelta T-cells. The gammadelta SPTCLs appear to be preferentially derived from the Vdelta2+ subset. Subcutaneous panniculitis-like T-cell lymphoma may be rapidly fatal or indolent; local therapy may be appropriate for some patients.
AuthorsK E Salhany, W R Macon, J K Choi, R Elenitsas, S R Lessin, R E Felgar, D M Wilson, G K Przybylski, J Lister, M A Wasik, S H Swerdlow
JournalThe American journal of surgical pathology (Am J Surg Pathol) Vol. 22 Issue 7 Pg. 881-93 (Jul 1998) ISSN: 0147-5185 [Print] United States
PMID9669350 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, CD
  • DNA, Neoplasm
  • Epstein-Barr virus encoded RNA 1
  • RNA, Viral
  • Receptors, Antigen, T-Cell, alpha-beta
  • Receptors, Antigen, T-Cell, gamma-delta
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD (analysis)
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • DNA, Neoplasm (analysis)
  • Female
  • Gene Rearrangement, T-Lymphocyte (genetics)
  • Genotype
  • Herpesvirus 4, Human (genetics)
  • Humans
  • Immunoenzyme Techniques
  • Immunophenotyping
  • In Situ Hybridization
  • Lymphoma, T-Cell, Cutaneous (chemistry, genetics, immunology, pathology)
  • Male
  • Middle Aged
  • Panniculitis (genetics, immunology, pathology)
  • RNA, Viral (analysis)
  • Receptors, Antigen, T-Cell, alpha-beta (analysis, genetics)
  • Receptors, Antigen, T-Cell, gamma-delta (analysis, genetics)
  • Skin Neoplasms (chemistry, genetics, immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: